Smartphone Intervention for Smoking Cessation and Adherence to Anti-Retroviral Therapy (ART) Among People Living With Human Immunodeficiency Virus (HIV)

• Status: Completed
• Trial end date: 2020-10-14
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to learn if a mindfulness-based smoking cessation smartphone app can help people quit smoking and stay on antiretroviral therapies.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Miami
• Treatments: Anti-Retroviral Agents; Nicotine

Criteria

Inclusion Criteria:

• • ≥ 18 years old

• Diagnosed with HIV

• have been prescribed ART medication in the prior 6 months

• have smoked ≥ 5 cigarettes/day in the past year

• be interested in making a quit attempt in the next 30 days

• own a smartphone (apple/android)and plan to keep it active for the following 3 months

• read/speak English

• be able to provide consent

• have no plans to move in the next 3 months

• not pregnant or planning to be pregnant in the following 3 months

Exclusion Criteria:

• Adults unable to consent

• Individuals who are not yet adults (infants, children, teenagers)

• Pregnant women

• Prisoners

• Those that regularly use tobacco products other than cigarettes

• Those that use drugs (methadone, alcohol, cocaine, marijuana) more than once-a-week.

• Have contraindication to NRT (past month myocardial infarction, history of serious arrhythmias/or unstable angina pectoris, dermatological disorder)

• Have cognitive/mental health impairment that inhibits mindfulness treatment

• Use other tobacco products regularly (which can interfere with biological verification of smoking cessation)

• Currently being treated for smoking cessation, alcoholism, or illicit drug use